Literature DB >> 11160162

Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance.

D S Ludwig1, N A Tritos, J W Mastaitis, R Kulkarni, E Kokkotou, J Elmquist, B Lowell, J S Flier, E Maratos-Flier.   

Abstract

Several lines of investigation suggest that the hypothalamic neuropeptide melanin-concentrating hormone (MCH) regulates body weight in mammals. Obese mice lacking functional leptin overexpress the MCH message in the fed or fasted state. Acute intracerebroventricular injection of MCH increases energy intake in rats. Mice lacking the MCH gene are lean. To test the hypothesis that chronic overexpression of MCH in mice causes obesity, we produced transgenic mice that overexpress MCH (MCH-OE) in the lateral hypothalamus at approximately twofold higher levels than normal mice. On the FVB genetic background, homozygous transgenic animals fed a high-fat diet ate 10% more and were 12% heavier at 13 weeks of age than wild-type animals, and they had higher systemic leptin levels. Blood glucose levels were higher both preprandially and after an intraperitoneal glucose injection. MCH-OE animals were insulin-resistant, as demonstrated by markedly higher plasma insulin levels and a blunted response to insulin; MCH-OE animals had only a 5% decrease in blood glucose after insulin administration, compared with a 31% decrease in wild-type animals. MCH-OE animals also exhibited a twofold increase in islet size. To evaluate the contribution of genetic background to the predisposition to obesity seen in MCH-OE mice, the transgene was bred onto the C57BL/6J background. Heterozygote C57BL/6J mice expressing the transgene showed increased body weight on a standard diet, confirming that MCH overexpression can lead to obesity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160162      PMCID: PMC199192          DOI: 10.1172/JCI10660

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

Authors:  J C Erickson; G Hollopeter; R D Palmiter
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

2.  Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.

Authors:  J C Brüning; J Winnay; S Bonner-Weir; S I Taylor; D Accili; C R Kahn
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

Review 3.  Obesity and the hypothalamus: novel peptides for new pathways.

Authors:  J S Flier; E Maratos-Flier
Journal:  Cell       Date:  1998-02-20       Impact factor: 41.582

4.  Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight.

Authors:  M Rossi; S J Choi; D O'Shea; T Miyoshi; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  1997-01       Impact factor: 4.736

5.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

6.  Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus.

Authors:  D S Ludwig; K G Mountjoy; J B Tatro; J A Gillette; R C Frederich; J S Flier; E Maratos-Flier
Journal:  Am J Physiol       Date:  1998-04

7.  Independent and additive effects of central POMC and leptin pathways on murine obesity.

Authors:  B A Boston; K M Blaydon; J Varnerin; R D Cone
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

8.  Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

Authors:  A Sainsbury; F Rohner-Jeanrenaud; I Cusin; K E Zakrzewska; P A Halban; R C Gaillard; B Jeanrenaud
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

9.  Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans.

Authors:  H Krude; H Biebermann; W Luck; R Horn; G Brabant; A Grüters
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

10.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.

Authors:  J C Erickson; K E Clegg; R D Palmiter
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

View more
  133 in total

1.  Melanin-concentrating hormone depresses L-, N-, and P/Q-type voltage-dependent calcium channels in rat lateral hypothalamic neurons.

Authors:  Xiao-Bing Gao; Anthony N van den Pol
Journal:  J Physiol       Date:  2002-07-01       Impact factor: 5.182

Review 2.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  Two naturally occurring mutations in the type 1 melanin-concentrating hormone receptor abolish agonist-induced signaling.

Authors:  Carmit Goldstein; Jonathan C Schroeder; Jean-Philippe Fortin; Jennifer M Goss; Scott E Schaus; Martin Beinborn; Alan S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2010-09-10       Impact factor: 4.030

4.  The role of melanin-concentrating hormone in conditioned reward learning.

Authors:  Andrew Sherwood; Marlena Wosiski-Kuhn; Truc Nguyen; Peter C Holland; Bernard Lakaye; Antoine Adamantidis; Alexander W Johnson
Journal:  Eur J Neurosci       Date:  2012-07-09       Impact factor: 3.386

5.  Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation.

Authors:  R L Hull; K Kodama; K M Utzschneider; D B Carr; R L Prigeon; S E Kahn
Journal:  Diabetologia       Date:  2005-06-04       Impact factor: 10.122

6.  High on food: the interaction between the neural circuits for feeding and for reward.

Authors:  Jing-Jing Liu; Diptendu Mukherjee; Doron Haritan; Bogna Ignatowska-Jankowska; Ji Liu; Ami Citri; Zhiping P Pang
Journal:  Front Biol (Beijing)       Date:  2015-02-10

7.  Inflammation-induced functional connectivity of melanin-concentrating hormone and IL-10.

Authors:  Dimitrios C Ziogas; Apostolos K A Karagiannis; Brenda M Geiger; Beatriz Gras-Miralles; Robert Najarian; Ofer Reizes; Leo R Fitzpatrick; Efi Kokkotou
Journal:  Peptides       Date:  2014-02-18       Impact factor: 3.750

8.  Microinjections of melanin concentrating hormone into the nucleus tractus solitarius of the rat elicit depressor and bradycardic responses.

Authors:  S N Brown; V C Chitravanshi; K Kawabe; H N Sapru
Journal:  Neuroscience       Date:  2007-10-05       Impact factor: 3.590

9.  Mechanism of the anti-obesity effects induced by a novel melanin-concentrating hormone 1-receptor antagonist in mice.

Authors:  Masahiko Ito; A Ishihara; A Gomori; H Matsushita; Makoto Ito; J M Metzger; D J Marsh; Y Haga; H Iwaasa; S Tokita; N Takenaga; N Sato; D J MacNeil; M Moriya; A Kanatani
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

10.  Regulation of adaptive behaviour during fasting by hypothalamic Foxa2.

Authors:  Jose P Silva; Ferdinand von Meyenn; Jessica Howell; Bernard Thorens; Christian Wolfrum; Markus Stoffel
Journal:  Nature       Date:  2009-12-03       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.